Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1996-02-23
1999-03-02
Minnifield, Nita
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
4241841, 424450, 514 12, A61K 3900, A61K 39002, A61K 39008, A61K 9127
Patent
active
058767355
ABSTRACT:
Methods for eliciting or enhancing immune responses to antigens, including tumor antigens, are provided. The methods employ polypeptides or nucleic acid compositions that contain at least a biologically active portion of a Leishmania braziliensis or Leishmania major homologue of the eukaryotic initiation factor 4A, or a variant thereof. Such polypeptides and compositions are useful for enhancing or eliciting a patient's cellular and/or humoral immune response, for instance within methods for treating tumors.
REFERENCES:
patent: 4897268 (1990-01-01), Tice et al.
patent: 5075109 (1991-12-01), Tice et al.
Reiner et al, J. Exp. Med. 179:447-56, Feb. 1994.
Heinzel et al. J. Exp. Med. 177:1505-09, May 1993.
Kim et al Nuc. Acids. Res. 21(8):2012, 1993.
Metz et al. Gene 120: 313-14, 1992.
Y.A.W. Skeiky et al., "Proliferative and Cytokine Responses of Human PBMC to Cloned Leishmania braziliensis Heat Shock and Ribosomal Antigens," Journal of Immunology 150 (8): 93a, 1993.
S.L. Reiner et al., "Leishmania Promastigotes Evade Interleukin 12 (IL-12) Induction by Macrophages and Stimulate a Broad Range of Cytokines from CD4.sup.+ T Cells During Initiation of Infection," J. Exp. Med. 179 (2): 447-456, 1994.
F.P. Heinzel et al., "Recombinant Interleukin 12 Cures Mice Infected with Leishmania major," J. Exp. Med. 177 (5): 1505-1509, 1993.
J.P. Sypek et al., "Resolution of Cutaneous Leishmaniasis: Interleukin 12 Initiates a Protective T Helper Type 1 Immune Response," J. Exp. Med. 177 (6): 1797-1802, 1993.
L.C.C. Afonso et al., "The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania major," Science 263 :235-237, 1994.
Reed and Scott, "T-Cell and cytokine responses in leishmaniasis," Current Opinion in Immunology 5 (4): 524-531, 1993.
Y.A.W. Skeiky et al., "A Recombinant Leishmania Antigen that Stimulates Human Peripheral Blood Mononuclear Cells to Express a Th1-Type Cytokine Profile and to Produce Interleukin 12," J. Exp. Med. 181 :1527-1537, 1995.
G. Trinchieri, "Interleukin-12 and its role in the generation of T.sub.H 1 cells," Immunology Today 14 (7): 335-338, 1993.
Ghalib et al., "IL-12 Enhances Th1-Type Responses in Human Leishmania donovani Infections," J. Immunol. 154 (9): 4623-4629, 1995.
Corixa Corporation
Minnifield Nita
LandOfFree
Methods for enhancement of protective immune responses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for enhancement of protective immune responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for enhancement of protective immune responses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-419941